Hemorrhagic Fever Viruses

Organizer(s): William E. Dowling and Thomas W. Geisbert

Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation.

Summary of Meeting:

Viral Hemorrhagic Fevers (VHF) are caused by a disparate group of viruses from four different virus families – Arenaviruses, Bunyaviruses, Filoviruses and Flaviviruses. These viruses have a substantial public health impact with few effective vaccines or antivirals available. Although their structures, vectors and replication cycles are very different, there are common pathogenic features between them. The meeting is designed to bring together the research communities around these individual viral families, to explore common pathways and mechanisms employed by the viruses, to discuss current medical countermeasures, and to foster collaborations. The specific aims of the conference are to: 1) Discuss the methods employed by hemorrhagic fever viruses to subvert host innate immune responses; 2) Assess the mechanisms causing endothelial dysfunction and coagulopathy that are hallmarks of VHF disease; 3) Look at the contributions of host genetics in disease progression; 4) Describe the state of the art in diagnostics; and 5) Present data on promising candidate vaccines and therapeutics. This symposium will occupy a unique niche as there is not a current scientific conference which brings these communities together in a focused manner.

Global Health Travel Award Deadline: July 19 2016

Scholarship Deadline: August 4 2016

Discounted Abstract Deadline: August 4 2016

Abstract Deadline: September 12 2016

Discounted Registration Deadline: October 4 2016

Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Mapp Biopharmaceutical, Inc.

Merck Vaccine Division

We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI126804-01
Funding for this conference was made possible (in part) by 1 R13 AI 126804 - 01 from the National Institute of Allergy and Infectious Diseases. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations